Roche Indonesia is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1971. Roche Indonesia is a subsidiary of the global healthcare company Roche, which was founded in 1896 by Fritz Hoffmann-La Roche in Basel, Switzerland. Roche is renowned for its innovative contributions to the pharmaceutical and diagnostics industries, focusing on advancing science to improve people's lives. In Indonesia, Roche is dedicated to providing high-quality pharmaceutical products and diagnostic solutions. The company's primary business line is pharmaceuticals, with a secondary focus on diagnostics. Roche Indonesia offers a range of products, including oncology, immunology, infectious diseases, ophthalmology, and neuroscience medications. Some of its well-known product brands include Avastin, Herceptin, and Actemra. Roche Indonesia operates several branches across the country, ensuring a strong local presence and accessibility to its products and services. Globally, Roche has a significant footprint, with operations in over 100 countries, making it one of the largest pharmaceutical companies worldwide. Roche collaborates with various healthcare providers, research institutions, and government bodies to enhance healthcare outcomes in Indonesia. The company is a member of several industry associations, contributing to the development of healthcare policies and standards. Roche Indonesia is committed to improving patient access to innovative treatments and diagnostics, aligning with Roche's global mission to do now what patients need next. The company strives to lead in personalized healthcare, leveraging its expertise in pharmaceuticals and diagnostics to deliver tailored healthcare solutions.
Headquarters
RT 005 RW 004
South Jakarta; Jakarta;
Postal Code: 12930
Contact Details: Purchase the PT Roche Indonesia report to view the information.
Website: http://www.roche.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service